Abstract | OBJECTIVE: This study was conducted to assess the health-related quality of life of patients treated with samples of an over-the-counter migraine medication. BACKGROUND: Population-based epidemiologic studies have reported that over 90% of an estimated 28 million migraine sufferers in the United States use both prescription and nonprescription medications for their migraine headaches, with 60% taking over-the-counter medications exclusively. Despite the widespread use of nonprescription drugs, no published literature to date has assessed migraineurs' health-related quality of life associated with use of over-the-counter headache medication. METHODS: This prospective and observational study evaluated the impact on health-related quality of life of patients from a managed care organization who were diagnosed with migraine and prescribed migraine medications. Patients were enrolled from four different medical groups and were requested to complete health-related quality-of-life questionnaires 2 and 4 months after they were provided with educational materials on migraine and samples of an over-the-counter migraine medication containing a combination of acetaminophen, aspirin, and caffeine. RESULTS: A total of 99 patients who chose an over-the-counter medication as their initial treatment for acute migraine occurring over the ensuing 4 months completed a baseline Short-Form 36, a validated and reliable general health status questionnaire. They then were retested at months 2 and 4. Results demonstrated significant improvements at months 2 and months 4 in one to four of the health-related quality-of-life dimensions measured relative to scores recorded before the patients were given access to the over-the-counter medication (P <.05). In addition, patients who initially took an over-the-counter medication to treat their migraine headaches reported increased frequency of relief. CONCLUSION: In the 4 months following availability of an over-the-counter migraine medication and educational migraine materials, health-related quality of life and frequency of relief improved for the managed care migraine sufferers who participated in this study.
|
Authors | Caroline T Burk, Alex Gilderman, Joyce Salas, David Berenbeim, Michael B Nichol |
Journal | Headache
(Headache)
Vol. 43
Issue 3
Pg. 191-201
(Mar 2003)
ISSN: 0017-8748 [Print] United States |
PMID | 12603637
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Analgesics, Non-Narcotic
- Drug Combinations
- Nonprescription Drugs
- Acetaminophen
- Caffeine
- Aspirin
|
Topics |
- Acetaminophen
(administration & dosage)
- Adult
- Aged
- Analgesics, Non-Narcotic
(therapeutic use)
- Aspirin
(administration & dosage)
- Caffeine
(administration & dosage)
- Drug Combinations
- Drug Prescriptions
- Female
- Health Status
- Humans
- Male
- Middle Aged
- Migraine Disorders
(drug therapy)
- Nonprescription Drugs
(therapeutic use)
- Prospective Studies
- Quality of Life
|